Bleselumab is under investigation in clinical trial NCT02921789 (Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients).
货号（Catalog No.）
CSD00397
通用名INN
Bleselumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Bleselumab is under investigation in clinical trial NCT02921789 (Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients).
别名(Alternative names)
4D11,ASKP-1240
靶点;物种(Specificity target name;species)
CD40/ TNFRSF5[Homo sapiens]
种类(Species)
Homo sapiens
受体鉴定(Receptor identification)
IgG4-kappa
化学信息
CAS
1453067-91-8
存储条件(Storage)
store at -80°C